Studies neural circuits in the brain and associated behavioral abnormalities.
The Kumar lab studies motivational reward pathways whose misregulation lead to behavioral abnormalities including addiction, attention deficit and hyperactivity disorder and depression. We use two functional genomics approaches in mice - forward genetic ethylnitrosourea (ENU) mutagenesis screens and quantitative trait loci (QTL) analysis - to identify genes and pathways that regulate these behaviors. Powerful and unbiased, forward genetic approaches make no a priori assumptions and only require a clear well-defined assay for gene discovery.
For circadian behavior, mutagenesis screens have identified core regulators of the autoregulatory feedback loop, such as Clock and Period. Although much is known about the circuitry that regulates motivation and reward behaviors, forward genetic approaches have not been widely applied to dissect these behaviors in mice. This leaves open the possibility of discovering novel genes, alleles and pathways that regulate these behaviors. Using high-throughput screening to discover mutants for acute cocaine response and open-field behavior, we have developed a collection of cocaine-response and open-field behavioral mutants that we are characterizing. We have genetically mapped three of these lines and are performing next-generation sequencing to identify the causative mutation. We have also used QTL analysis of two closely related mouse substrains to identify a novel gene, Cyfip2, that regulates cocaine response. Using genetics as its foundation, and a combination of biochemistry, physiology and imaging techniques, we dissect complex behavior in mammals.
As part of the NIH Neurogenomics project (Vitaterna, Pinto and Takahashi, 2007) we screened 10,000 mice per year for five years in six phenotypic domains. Vivek led the psychostimulant response screen in which acute response to cocaine was measured as a locomotor output assay. He developed a high throughput video-based screening facility capable of testing 96 mice per day with only one technician, in a 1.5 hour combined open-field and psychostimulant response assay. At UT Southwestern Vivek conducted a second-generation screen that had a 10-fold increase in detection of true positive mutants (Takahashi, Shimomura and Kumar, 2008, Kumar et. al., 2011). Through these two screens, the Kumar Lab has a panel of mutants that we are characterizing and positionally cloning. Some of the mutants are described at Kumarlab.org.
Utilizing quantitative genetics and positional cloning with two closely related mouse substrains, C57BL/6J (B6J – The Jackson Laboratory) and C57BL/6N (B6N – NIH), we have identified Cytoplasmic FMRP Interacting Protein 2 (Cyfip2) as a key regulator of cocaine response in mammals. This work has three major implications. First, we identified a mutation at the nucleotide level utilizing QTL analysis and provided genetic, biochemical and physiological evidence that CYFIP2 is a regulator of acute and sensitized cocaine response. Second, with over 20 commercially available C57BL/6 substrains, many with known behavioral differences, we describe a framework to utilize mouse substrains as a rich genetic source for discovering new genes and alleles that regulate behavior. If other substrains such as C3H/He and DBA/2 are included, hundreds of mouse substrains, many with known phenotypic differences, are available for analysis. Third, as the phenotyping phase of IKMC begins, care must be taken when comparing new behavioral data from B6N substrains with existing data from B6J, particularly for behavioral phenotypes (Kumar et. al., Science 2013).